These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 26886421)

  • 1. Sentinel lymph node biopsy in breast cancer: a technical and clinical appraisal.
    Manca G; Tardelli E; Rubello D; Gennaro M; Marzola MC; Cook GJ; Volterrani D
    Nucl Med Commun; 2016 Jun; 37(6):570-6. PubMed ID: 26886421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axillary Staging After Neoadjuvant Chemotherapy for Breast Cancer: A Pilot Study Combining Sentinel Lymph Node Biopsy with Radioactive Seed Localization of Pre-treatment Positive Axillary Lymph Nodes.
    Diego EJ; McAuliffe PF; Soran A; McGuire KP; Johnson RR; Bonaventura M; Ahrendt GM
    Ann Surg Oncol; 2016 May; 23(5):1549-53. PubMed ID: 26727919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy of sentinel lymph node biopsy in determining the axillary lymph node metastasis.
    Okur O; Sagiroglu J; Kir G; Bulut N; Alimoglu O
    J Cancer Res Ther; 2020; 16(6):1265-1268. PubMed ID: 33342782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentinel lymph node mapping in breast cancer: a critical reappraisal of the internal mammary chain issue.
    Manca G; Volterrani D; Mazzarri S; Duce V; Svirydenka A; Giuliano A; Mariani G
    Q J Nucl Med Mol Imaging; 2014 Jun; 58(2):114-26. PubMed ID: 24835288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patient.
    Franceschini G; Di Leone A; Sanchez AM; D'Archi S; Terribile D; Magno S; Scardina L; Masetti R
    Ann Ital Chir; 2020; 91():465-468. PubMed ID: 32312945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection.
    Kuijt GP; van de Poll-Franse LV; Voogd AC; Nieuwenhuijzen GA; Roumen RM
    Eur J Surg Oncol; 2007 Sep; 33(7):832-7. PubMed ID: 17197151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does Conservative Surgery for Breast Carcinoma Still Require Axillary Lymph Node Evaluation? A Retrospective Analysis of 1156 Consecutive Women With Early Breast Cancer.
    Marrazzo A; Damiano G; Taormina P; Buscemi S; Lo Monte AI; Marrazzo E
    Clin Breast Cancer; 2017 Apr; 17(2):e53-e57. PubMed ID: 27840075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
    Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
    Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraoperative sentinel node biopsy by one-step nucleic acid amplification (OSNA) avoids axillary lymphadenectomy in women with breast cancer treated with neoadjuvant chemotherapy.
    Navarro-Cecilia J; Dueñas-Rodríguez B; Luque-López C; Ramírez-Expósito MJ; Martínez-Ferrol J; Ruíz-Mateas A; Ureña C; Carrera-González MP; Mayas MD; Martínez-Martos JM
    Eur J Surg Oncol; 2013 Aug; 39(8):873-9. PubMed ID: 23711734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between Ultrasound and Pathologic Status of Axillary Lymph Nodes in Clinically Node-negative Breast Cancer Patients.
    Bailey A; Layne G; Shahan C; Zhang J; Wen S; Radis S; Richmond B; Partin J; Hazard H
    Am Surg; 2015 Sep; 81(9):865-9. PubMed ID: 26350662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of CEUS-guided sentinel lymph node biopsy in early-stage breast cancer: a study review and meta-analysis.
    Cui Q; Dai L; Li J; Xue J
    World J Surg Oncol; 2020 May; 18(1):112. PubMed ID: 32471428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.
    Reitsamer R; Peintinger F; Rettenbacher L; Prokop E
    J Surg Oncol; 2003 Oct; 84(2):63-7. PubMed ID: 14502778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
    Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
    J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel lymph node biopsy indications and controversies in breast cancer.
    Wiatrek R; Kruper L
    Maturitas; 2011 May; 69(1):7-10. PubMed ID: 21411254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for carcinoma of the breast.
    Schwartz GF; Tannebaum JE; Jernigan AM; Palazzo JP
    Cancer; 2010 Mar; 116(5):1243-51. PubMed ID: 20087958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel lymph node biopsy compared with axillary lymph node dissection in early breast cancer: a meta-analysis.
    Wang Z; Wu LC; Chen JQ
    Breast Cancer Res Treat; 2011 Oct; 129(3):675-89. PubMed ID: 21743996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved false negative rate of axillary status using sentinel lymph node biopsy and ultrasound-suspicious lymph node sampling in patients with early breast cancer.
    Wang Y; Dong H; Wu H; Zhang L; Yuan K; Chen H; Jiao M; Fu R
    BMC Cancer; 2015 May; 15():382. PubMed ID: 25956308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel Lymph Node Biopsy in Breast Cancer: Indications, Contraindications, and Controversies.
    Manca G; Rubello D; Tardelli E; Giammarile F; Mazzarri S; Boni G; Chondrogiannis S; Marzola MC; Chiacchio S; Ghilli M; Roncella M; Volterrani D; Colletti PM
    Clin Nucl Med; 2016 Feb; 41(2):126-33. PubMed ID: 26447368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continued axillary sampling is unnecessary and provides no further information to sentinel node biopsy in staging breast cancer.
    Gui GP; Joubert DJ; Reichert R; Ward A; Lakhani S; Osin P; Nerurkar A; A'Hern R; Benson K; Underwood SR
    Eur J Surg Oncol; 2005 Sep; 31(7):707-14. PubMed ID: 15993028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.